Clinical Trial Update: Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC

View source ↗

Summary

A completed study validating molecular diagnostic assays to detect cancer biomarkers in blood and primary tumors from patients with ER+/HER2- metastatic breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Pharmassist Ltd | Conditions: Breast Cancer | Status: COMPLETED